WallStreetZenWallStreetZen

NASDAQ: BRNS
Barinthus Biotherapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BRNS

Based on 1 analyst offering 12 month price targets for Barinthus Biotherapeutics PLC.
Min Forecast
$8.00+218.73%
Avg Forecast
$8.00+218.73%
Max Forecast
$8.00+218.73%

Should I buy or sell BRNS stock?

Based on 1 analyst offering ratings for Barinthus Biotherapeutics PLC.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BRNS stock forecasts and price targets.

BRNS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-22

1 of 1

Forecast return on equity

Is BRNS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is BRNS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BRNS revenue forecast

What is BRNS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.8M+124.44%
Avg 2 year Forecast
$396.0k-50.62%
Avg 3 year Forecast
$3.1M+280.3%
BRNS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BRNS revenue growth forecast

How is BRNS forecast to perform vs Biotechnology companies and vs the US market?
Company
49.52%
Industry
37.5%
Market
10.08%
BRNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BRNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BRNS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BRNS$2.51$8.00+218.73%Buy
FGEN$0.98N/AN/A
CLRB$3.06$20.00+553.59%Strong Buy
IOBT$1.46$8.00+447.95%Buy
ORMP$2.37N/AN/A
View Top Biotech Stocks

Barinthus Biotherapeutics Stock Forecast FAQ

Is Barinthus Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BRNS) stock is to Buy BRNS stock.

Out of 1 analyst, 0 (0%) are recommending BRNS as a Strong Buy, 1 (100%) are recommending BRNS as a Buy, 0 (0%) are recommending BRNS as a Hold, 0 (0%) are recommending BRNS as a Sell, and 0 (0%) are recommending BRNS as a Strong Sell.

If you're new to stock investing, here's how to buy Barinthus Biotherapeutics stock.

What is BRNS's revenue growth forecast for 2024-2026?

(NASDAQ: BRNS) Barinthus Biotherapeutics's forecast annual revenue growth rate of 49.52% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Barinthus Biotherapeutics's revenue in 2024 is $802,000.On average, 1 Wall Street analysts forecast BRNS's revenue for 2024 to be $70,058,182, with the lowest BRNS revenue forecast at $70,058,182, and the highest BRNS revenue forecast at $70,058,182. On average, 1 Wall Street analysts forecast BRNS's revenue for 2025 to be $15,412,800, with the lowest BRNS revenue forecast at $15,412,800, and the highest BRNS revenue forecast at $15,412,800.

In 2026, BRNS is forecast to generate $118,709,697 in revenue, with the lowest revenue forecast at $38,921,212 and the highest revenue forecast at $198,498,181.

What is BRNS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BRNS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BRNS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BRNS price target, the average BRNS price target is $8.00, with the highest BRNS stock price forecast at $8.00 and the lowest BRNS stock price forecast at $8.00.

The Wall Street analyst predicted that Barinthus Biotherapeutics's share price could reach $8.00 by Apr 22, 2025. The average Barinthus Biotherapeutics stock price prediction forecasts a potential upside of 218.73% from the current BRNS share price of $2.51.

What is BRNS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BRNS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.